Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
- 2017 -
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
January 2017 - 33 products
L
IP
CI
Jadenu 90 mg
30
191.20
221.40
10 %
Coated tablets: Deferasiroxum 90 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 90 mg
90
487.57
539.15
10 %
Coated tablets: Deferasiroxum 90 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 180 mg
30
313.58
352.65
10 %
Coated tablets: Deferasiroxum 180 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 180 mg
90
799.62
873.75
10 %
Coated tablets: Deferasiroxum 180 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 360 mg
30
514.27
567.80
10 %
Coated tablets: Deferasiroxum 360 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 360 mg
90
1311.37
1422.45
10 %
Coated tablets: Deferasiroxum 360 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Rosuvastatin Spirig HC 5 mg
30
7.12
16.95
10 %
Coated tablets: Rosuvastatinum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rosuvastatin Spirig HC 5 mg
100
23.75
42.20
10 %
Coated tablets: Rosuvastatinum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rosuvastatin Spirig HC 10 mg
30
8.12
18.05
10 %
Coated tablets: Rosuvastatinum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rosuvastatin Spirig HC 10 mg
100
27.08
45.80
10 %
Coated tablets: Rosuvastatinum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rosuvastatin Spirig HC 20 mg
30
11.78
29.20
10 %
Coated tablets: Rosuvastatinum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Rosuvastatin Spirig HC 20 mg
100
39.28
59.05
10 %
Coated tablets: Rosuvastatinum 20 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Fosfomycin-Mepha 3 g
4.02
13.60
10 %
Pulver im Beutel zur Herstellung einer Lösung zum Einnehmen: Fosfomycinum 3 g
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
CM
Traumalix forte EmGel
40 g
5.97
11.05
10 %
Gel: Etofenamatum 100 mg
Drossapharm AG
D / SL
FB
G
IP
CI
CM
Traumalix forte EmGel
100 g
13.14
24.25
10 %
Gel: Etofenamatum 100 mg
Drossapharm AG
D / SL
FB
G
L
IP
CI
PP
Alecensa 150 mg
224
4344.43
4741.25
10 %
Capsules: Alectinibum 150 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
PP
Ibrance 75 mg
21
1973.56
2162.80
10 %
Capsules: Palbociclibum 75 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Ibrance 100 mg
21
1973.56
2162.80
10 %
Capsules: Palbociclibum 100 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Ibrance 125 mg
21
1973.56
2162.80
10 %
Capsules: Palbociclibum 125 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
Ph
Laitea
14
6.98
12.90
10 %
Capsules: Lavandulae Aetheroleum 80 mg
Schwabe Pharma AG
D / SL
FB
G
L
IP
CI
Ph
Laitea
28
13.95
25.75
10 %
Capsules: Lavandulae Aetheroleum 80 mg
Schwabe Pharma AG
D / SL
FB
G
L
IP
CI
Ph
Laitea
56
24.55
45.35
10 %
Capsules: Lavandulae Aetheroleum 80 mg
Schwabe Pharma AG
D / SL
FB
G
IP
CI
CM
Traumalix Gel
40 g
PR
PR
k.A.
Gel: Etofenamatum 50 mg
Drossapharm AG
D
FB
G
IP
CI
CM
Traumalix Gel
100 g
PR
PR
k.A.
Gel: Etofenamatum 50 mg
Drossapharm AG
D
FB
G
IP
CI
CM
Amavita Glycolax
18
PR
PR
k.A.
Suppositories: Glycerolum 2250 mg
Amavita Health Care AG
D / LPPV
FB
G
IP
Rosuvastatin Spirig HC 40 mg
30
PR
PR
k.A.
Coated tablets: Rosuvastatinum 40 mg
Spirig HealthCare AG
B
FB
G
IP
Rosuvastatin Spirig HC 40 mg
100
PR
PR
k.A.
Coated tablets: Rosuvastatinum 40 mg
Spirig HealthCare AG
B
FB
G
IP
CI
CM
Circlet
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Organon GmbH
B / LPPV
FB
G
IP
CI
CM
Circlet
3
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Organon GmbH
B / LPPV
FB
G
IP
Phenylephrin Sintetica 10
mg/ml
10 x 1 ml
PR
PR
k.A.
soluzione iniettabile (s.c., i.m.) / concentrato per infusione (i.v.): Phenylephrini Hydrochloridum 10 mg/ml
Sintetica SA
B
FB
G
IP
Phenylephrin Sintetica 0.1
mg/ml
10 x 5 ml
PR
PR
k.A.
soluzione iniettabile (s.c., i.m.) o per infusione (i.v.): Phenylephrini Hydrochloridum
Sintetica SA
B
FB
G
IP
Phenylephrin Sintetica 0.1
mg/ml
50 ml
PR
PR
k.A.
soluzione iniettabile (s.c., i.m.) o per infusione (i.v.): Phenylephrini Hydrochloridum
Sintetica SA
B
FB
G
IP
Phenylephrin Sintetica 0.1
mg/ml
10 x 10 ml
PR
PR
k.A.
soluzione iniettabile (s.c., i.m.) o per infusione (i.v.): Phenylephrini Hydrochloridum
Sintetica SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
